| Literature DB >> 34295726 |
Xiaoqiang Xue1, Dong Wang1, Zhigang Ji1, Yi Xie1.
Abstract
BACKGROUND: Postoperative ileus (POI) is one of the most common complications after laparoscopic radical cystectomy (LRC). Albeit its high incidence, its risk factors are obscure, and few studies have attempted to explore them. Meanwhile, risk-assessing tools for predicting its happening are lacking.Entities:
Keywords: Urinary bladder neoplasms; cystectomy; ileus; risk factors; weights and measures
Year: 2021 PMID: 34295726 PMCID: PMC8261424 DOI: 10.21037/tau-21-112
Source DB: PubMed Journal: Transl Androl Urol ISSN: 2223-4683
Univariate analysis of demographic, clinical and pathological factors associated with POI following LRC
| Variable | Non-POI | POI | P value |
|---|---|---|---|
| Patients, n (%) | 134 (68.02) | 63 (31.98) | NA |
| Gender, n (%) | 0.319 | ||
| Male | 114 (69.51) | 50 (30.49) | |
| Female | 20 (60.61) | 13 (39.39) | |
| Mean age (years) | 44–90 (65.13±8.79) | 42–83 (62.68±9.87) | 0.084* |
| BMI (kg/m2) | 14.70–33.33 (23.79±3.26) | 16.02–32.97 (24.48±3.30) | 0.176 |
| Hospital day (days) | 6–42 (12.83±5.67) | 9–47 (21.08±8.07) | NA |
| Chronic constipation, n (%) | 21 (15.67) | 25 (39.68) | <0.001* |
| Laxative dosage (packs) | 2–6 (2.96±0.81) | 1–5 (3.32±0.81) | 0.006* |
| Antibiotics types | |||
| Fluoroquinolones, n (%) | 13 (9.70) | 3 (4.76) | – |
| 2nd Gen. Cephalosporins, n (%) | 83 (61.94) | 35 (55.56) | 0.369 |
| 3rd Gen. Cephalosporins, n (%) | 38 (28.36) | 25 (39.68) | 0.221 |
| Hypertension, n (%) | 53 (39.55) | 24 (38.10) | 0.845 |
| Diabetes, n (%) | 18 (13.43) | 13 (20.63) | 0.198 |
| Smoking, n (%) | 73 (54.48) | 29 (46.03) | 0.269 |
| Hard-drinking, n (%) | 37 (27.61) | 13 (20.63) | 0.296 |
| Multiple TURBts, n (%) | 59 (44.03) | 25 (39.68) | 0.565 |
| Chemotherapy, n (%) | 48 (35.82) | 21 (33.33) | 0.733 |
| Preoperative hemoglobin (g/L) | 77–171 (130.62±19.62) | 73–167 (132.24±18.69) | 0.584 |
| Preoperative albumin (g/L) | 24–49 (40.16±4.43) | 31–48 (40.56±3.32) | 0.526 |
| Preoperative creatinine (μmol/L) | 50–133 (80.75±18.00) | 51–145 (87.40±22.14) | 0.029 |
| Previous abdominal surgery, n (%) | 30 (22.39) | 17 (26.98) | 0.481 |
| Surgery time (minutes) | 210–625 (364.40±79.37) | 235–640 (396.59±81.28) | 0.011* |
| Intraoperative blood loss (mL) | 50–1,600 (456.72±355.49) | 50–3,000 (465.87±531.76) | 0.887 |
| Blood transfusion, n (%) | 0–1,600 (171.64±335.16) | 0–1,600 (193.65±365.09) | 0.677 |
| Urine derivation | 0.011* | ||
| Intestine-related (orthotopic/conduits), n (%) | 79 (58.96) | 49 (77.78) | |
| Ureterocutaneostomy, n (%) | 55 (41.04) | 14 (22.22) | |
| Postoperative walking time (days) | 1–4 (2.30±0.51) | 2–5 (2.97±0.71) | <0.001* |
| Postoperative farting time (days) | 1–10 (3.01±1.15) | 2–10 (4.27±1.59) | NA |
| Postoperative antibiotics usage (days) | 2–11 (5.65±1.99) | 1–15 (6.52±3.02) | 0.020* |
| T staging | |||
| T0 | 12 (8.96) | 7 (11.11) | / |
| T1 | 28 (20.90) | 14 (22.22) | 0.789 |
| T2 | 39 (29.10) | 24 (38.10) | 0.921 |
| T3 | 46 (34.33) | 15 (23.81) | 0.300 |
| T4 | 9 (6.72) | 3 (4.76) | 0.494 |
| N staging | |||
| N0 | 96 (71.64) | 53 (84.13) | / |
| N1 | 11 (8.21) | 4 (6.35) | 0.493 |
| N2 | 27 (20.15) | 6 (9.52) | 0.259 |
| N3 | 0 (0.00) | 0 (0.00) | NA |
| Pathological results | 1.00 (NA) | ||
| Urothelial carcinoma | 133 (99.25) | 63 (100.00) | |
| SCNECB | 1 (0.75) | 0 (0.00) | |
| Incidental prostate carcinoma (iPCA) | 0.702 | ||
| With iPCA | 22 (16.42) | 9 (14.29) | |
| Without iPCA | 112 (83.58) | 54 (85.71) | |
| Lymph nodes yields | 0–58 (16.29±9.52) | 0–36 (16.25±7.14) | 0.980 |
| Tumor diameter (cm) | 0–7 (2.77±1.61) | 0–7 (2.61±1.66) | 0.514 |
| ICU hospitalization, n (%) | 30 (22.39) | 18 (28.57) | 0.347 |
| Time of analgesics used in ICU (hours) | 2–8 (3.87±1.53) | 2–7 (3.98±1.62) | 0.811 |
Data are presented as the range (mean ± standard deviation) or the number (%) of patients. *, indicates statistical significance. NA means this entry is not logically applicable. – means dummy variable. SCNECB, small cell neuroendocrine carcinoma of the bladder; ICU, intensive care unit.
Multivariate analysis of risk factors associated with POI
| Variable | Coefficient (B) | Odds ratio | 95% CI | P value |
|---|---|---|---|---|
| Age | −0.042 | 0.959 | 0.919–1.000 | 0.052 |
| Chronic constipation | 0.876 | 2.400 | 1.023–5.632 | 0.044* |
| Laxative dosage | 0.474 | 1.607 | 1.016–2.542 | 0.043* |
| Preoperative creatinine | 0.020 | 1.020 | 1.001–1.039 | 0.041* |
| Surgery time | 0.002 | 1.002 | 0.997–1.006 | 0.506 |
| Intestine related urine derivation | 0.890 | 2.436 | 1.002–5.922 | 0.039 |
| Postoperative antibiotics usage | 0.101 | 1.106 | 0.946–1.293 | 0.204 |
| Postoperative walking time | 1.642 | 5.164 | 2.726–9.780 | <0.001* |
*, indicates statistical significance.
Point system for the prediction of POI
| Risk factor and categories | Points |
|---|---|
| Chronic constipation | |
| No | 0 |
| Yes | 1 |
| Intestine related urine derivation | |
| No | 0 |
| Yes | 1 |
| Preoperative creatinine (μmol/L) | |
| <80 | −0.5 |
| 80–99 | 0 |
| 100–119 | 0.5 |
| ≥120 | 1 |
| Increased laxative dosage (packs) | |
| 1–2 | 0 |
| 3–4 | 1 |
| 5–6 | 2 |
| Postoperative first-time walking (days) | |
| 1–2 | −3 |
| 3 | 0 |
| 4–5 | 3 |
Predicted risk of POI
| Point total | Risk | Point total | Risk | Point total | Risk |
|---|---|---|---|---|---|
| −3.5 | 0.044 | 0.5 | 0.608 | 4.5 | 0.981 |
| −3 | 0.067 | 1 | 0.706 | 5 | 0.988 |
| −2.5 | 0.100 | 1.5 | 0.789 | 5.5 | 0.992 |
| −2 | 0.147 | 2 | 0.853 | 6 | 0.995 |
| −1.5 | 0.211 | 2.5 | 0.900 | 6.5 | 0.997 |
| −1 | 0.293 | 3 | 0.933 | 7 | 0.998 |
| −0.5 | 0.392 | 3.5 | 0.956 | 7.5 | 0.999 |
| 0 | 0.500 | 4 | 0.971 | 8 | 0.999 |
External cohort for validation examination
| Patient | Constipation | Bowel preparation (packs) | Creatinine (μmol/L) | First-time ambulation (days) | Intestine-related surgery | Score | Predicted risk | Calculated risk | Real-world POI occurrence |
|---|---|---|---|---|---|---|---|---|---|
| A | No | 2 | 71 | 3 | Yes | 0.5 | 0.608 | 0.679 | No |
| B | No | 2 | 84 | 3 | Yes | 1 | 0.706 | 0.733 | Yes |
| C | Yes | 3 | 88 | 3 | Yes | 3 | 0.993 | 0.920 | Yes |
| D | No | 3 | 63 | 2 | Yes | −1.5 | 0.211 | 0.359 | No |
| E | No | 2 | 68 | 2 | Yes | −2.5 | 0.100 | 0.278 | No |
| F | No | 3 | 85 | 2 | Yes | −1 | 0.293 | 0.466 | No |
| G | No | 2 | 65 | 2 | Yes | −2.5 | 0.100 | 0.267 | No |
| H | No | 2 | 69 | 1 | Yes | −2.5 | 0.100 | 0.071 | No |
| I | Yes | 2 | 115 | 3 | Yes | 2.5 | 0.900 | 0.925 | Yes |
| J | No | 2 | 74 | 2 | Yes | −2.5 | 0.100 | 0.303 | No |
| K | No | 3 | 115 | 3 | Yes | 2.5 | 0.900 | 0.891 | Yes |
| L | Yes | 2 | 107 | 3 | Yes | 2.5 | 0.900 | 0.913 | Yes |
| M | No | 2 | 84 | 2 | Yes | −2 | 0.147 | 0.347 | No |
| N | Yes | 3 | 66 | 3 | Yes | 2.5 | 0.900 | 0.881 | Yes |
| O | Yes | 3 | 51 | 4 | Yes | 5.5 | 0.992 | 0.966 | Yes |
| P | No | 2 | 77 | 2 | No | −3.5 | 0.044 | 0.159 | No |
| Q | No | 3 | 82 | 2 | No | −2 | 0.147 | 0.252 | No |
| R | No | 2 | 121 | 2 | No | −2 | 0.147 | 0.313 | No |
| S | No | 2 | 57 | 3 | No | −0.5 | 0.392 | 0.397 | No |
| T | Yes | 3 | 86 | 3 | No | 2 | 0.853 | 0.819 | Yes |